Literature DB >> 7777206

Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.

D J Henry1, C Chavkin.   

Abstract

The neuronal cannabinoid receptor clone was expressed of saturable [3H]WIN 55,212-2 binding sites. Co-expression of the cannabinoid receptor with cRNA coding for the G-protein-gated inwardly rectifying K+ channel (GIRK1) resulted in oocytes exhibiting large inward K+ currents in response to the cannabinoid agonist WIN 55,212-2. The activation of the potassium current by WIN 55,212-2 was dose-dependent with an EC50 of 630 nM. These results suggest that activation of inwardly rectifying K+ channels may be an additional effector mechanism for brain cannabinoid receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777206     DOI: 10.1016/0304-3940(95)11289-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.

Authors:  D Robbe; G Alonso; F Duchamp; J Bockaert; O J Manzoni
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro.

Authors:  C W Vaughan; I S McGregor; M J Christie
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids.

Authors:  Marco A Diana; Carole Levenes; Ken Mackie; Alain Marty
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

Review 5.  An overview of the cannabinoid type 2 receptor system and its therapeutic potential.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Curr Opin Anaesthesiol       Date:  2018-08       Impact factor: 2.706

6.  Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

Authors:  M Shen; T M Piser; V S Seybold; S A Thayer
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

Review 7.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

8.  Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.

Authors:  Paolo Gubellini; Barbara Picconi; Monica Bari; Natalia Battista; Paolo Calabresi; Diego Centonze; Giorgio Bernardi; Alessandro Finazzi-Agrò; Mauro Maccarrone
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 9.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 10.  Marijuana and cannabinoid regulation of brain reward circuits.

Authors:  Carl R Lupica; Arthur C Riegel; Alexander F Hoffman
Journal:  Br J Pharmacol       Date:  2004-08-16       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.